BioHarvest Sciences Inc. Common Stock

$3.72-5.10%($-0.20)
TickerSpark Score
65/100
Solid
75
Valuation
40
Profitability
100
Growth
80
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BHST research report →

52-Week Range2% of range
Low $3.57
Current $3.72
High $12.80

Companywww.bioharvest.com

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments.

CEO
Ilan Sobel
IPO
2021
Employees
87
HQ
Vancouver, BC, CA

Price Chart

-40.38% · this period
$12.65$8.17$3.69May 20Nov 18May 20

Valuation

Market Cap
$64.46M
P/E
-7.37
P/S
1.83
P/B
3.66
EV/EBITDA
-9.08
Div Yield
0.00%

Profitability

Gross Margin
59.50%
Op Margin
-16.19%
Net Margin
-32.54%
ROE
-88.01%
ROIC
-14.43%

Growth & Income

Revenue
$34.51M · 37.00%
Net Income
$-11,135,000 · 13.77%
EPS
$-0.60 · 25.00%
Op Income
$-5,575,000
FCF YoY
-0.65%

Performance & Tape

52W High
$12.80
52W Low
$3.57
50D MA
$4.24
200D MA
$6.51
Beta
1.37
Avg Volume
28.08K

Get TickerSpark's AI analysis on BHST

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our BHST Coverage

We haven't published any research on BHST yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate BHST Report →

Similar Companies